CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-30 | Trencher Daniel CHIEF STRATEGY OFFICER | Option exercise · Restricted Stock Units | −2,790 | 16,742 | ||
| 2024-08-30 | Waters Michael Willem CHIEF OPERATING OFFICER | Option exercise | +2,113 | 76,327 | ||
| 2024-08-30 | Waters Michael Willem CHIEF OPERATING OFFICER | Option exercise | +6,200 | 82,527 | ||
| 2024-08-30 | Waters Michael Willem CHIEF OPERATING OFFICER | Option exercise · Performance Stock Units | −2,113 | 12,679 | ||
| 2024-08-30 | Waters Michael Willem CHIEF OPERATING OFFICER | Option exercise · Restricted Stock Units | −6,200 | 37,204 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,056 | 38,715 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,348 | 40,063 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +3,100 | 43,163 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units | −1,056 | 6,341 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −1,348 | 2,696 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −3,100 | 18,602 | ||
| 2024-08-30 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise | +792 | 32,922 | ||
| 2024-08-30 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise | +2,325 | 35,247 | ||
| 2024-08-30 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise · Performance Stock Units | −792 | 4,756 | ||
| 2024-08-30 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −2,325 | 13,952 | ||
| 2024-08-15 | Smith Mark Douglas Director | Purchase | +4,000 | $7.08 | $28K | 8,355 |
| 2024-08-12 | Nanis Nikolaos P. Chief Technology Officer | Sale | −206 | $7.14 | $1K | 73,588 |
| 2024-08-09 | Nanis Nikolaos P. Chief Technology Officer | Option exercise | +568 | 73,794 | ||
| 2024-08-09 | Nanis Nikolaos P. Chief Technology Officer | Option exercise · Restricted Stock Units | −568 | 0 | ||
| 2024-08-07 | Verstraete Stephany CHIEF MARKETING OFFICER | Sale 10b5-1 | −15,000 | $7.60 | $114K | 45,158 |
Page 25 of 74 · 1,476 trades